Status:
COMPLETED
Comparison Between Retrolaminar and Medial Branch Block in Cervical Facet Joint Arthropathy
Lead Sponsor:
Mansoura University
Conditions:
Joint Pain
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Cervical facet joints have been implicated as a source of chronic pain in 54-67 % patients with chronic posterior neck pain.1 Intraarticular injections, medial branch nerve blocks and neurolysis of me...
Detailed Description
This prospective randomized open comparative study will be conducted in pain clinic, Mansoura University Hospitals. The study will be approved by the Ethics Research Committee of the Faculty of Medici...
Eligibility Criteria
Inclusion
- Patients more than 18 years old of both genders with cervical facet joint arthropathy confirmed by magnetic resonance imaging (MRI) and neck manual examination and not responding to conservative treatments
- numeric rating scale (NRS) ≥ 4 that ranged from 0 (no pain) to 10 (extreme pain).,
- American society of Anesthesiology Physical Status class I and II,
- Body mass index ˂ 30
Exclusion
- The exclusion criteria are patient refusal
- local or systemic sepsis, coagulopathy,
- unstable cardiovascular and respiratory diseases,
- previous neurological deficits,
- history of psychiatric disorders,
- history of drug abuse,
- distorted local anatomy,
- those who were allergic to the used medications .
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05184881
Start Date
December 1 2021
End Date
December 30 2022
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yahya Wahba
Al Mansurah, Egypt